Biotech & pharma
New nanoparticles shrink tumours in mice
By By Anne Trafton, News Office | 17 Aug 2012
Particles that shut off cancer genes could also allow researchers to screen potential drug targets more rapidly
Simple mathematical computations underlie brain circuits
By By Anne Trafton, MIT News Office | 09 Aug 2012
Discovery of how some neurons inhibit others could shed light on autism, other neurological disorders. By Anne Trafton, MIT News Office
Protein that boosts longevity may protect against diabetes
By By Anne Trafton, MIT News Office | 08 Aug 2012
New research has identified a protein that slows ageing in mice and other animals, also protects against the ravages of a high-fat diet, including diabetes, according to a new MIT study
New study finds link between cell division and growth rate
By By Anne Trafton, MIT News Office | 07 Aug 2012
It's in our genes: why women outlive men
06 Aug 2012
A flash of light changes cell activity — and understanding of disease
By By Bill Hathway | 31 Jul 2012
New melanoma driver genes found in largest DNA sequencing study to date
By By Helen Dodson | 31 Jul 2012
New proteins inhibit HIV infection in cell cultures
By By Helen Dodson | 30 Jul 2012
New recruits in the fight against disease
28 Jul 2012
Researchers first to determine entire genetic sequence of individual human sperm
By By Krista Conger | 25 Jul 2012
Stanford researchers produce first complete computer model of an organism
By By Max McClure | 24 Jul 2012
Mystery peeled off banana genome
By By Daniel Stolte | 23 Jul 2012
Searching genomic data faster
11 Jul 2012
Latest articles
Featured articles
The decoupling paradox: Why Wall Street keeps funding AI despite $100 oil
By Axel Miller | 11 May 2026
AI infrastructure stocks continue rallying despite $100 oil as investors bet on productivity gains and semiconductor demand in 2026.
Hybrid bonding gains attention as AI chip packaging demand grows
By Cygnus | 23 Apr 2026
Hybrid bonding is driving AI chip packaging demand as backend technologies gain importance in the semiconductor supply chain.
The agentic transition: how enterprises are scaling AI from pilot to profit
By Cygnus | 22 Apr 2026
AI has entered its execution era. Discover how companies like Valeo and Microsoft are scaling agentic AI systems—from copilots to autonomous workflows driving real business impact.
Post-splashdown: What Artemis II taught us about the ‘deep space wall’
By Axel Miller | 15 Apr 2026
Artemis II splashdown marks a breakthrough in deep space exploration. Discover AVATAR radiation data, Orion’s distance record, and insights shaping NASA’s 2028 Moon mission.
Can aviation go green? The multi-billion dollar race for sustainable fuel
By Cygnus | 10 Apr 2026
Airlines are racing to adopt sustainable aviation fuel, but limited supply and high costs challenge the future of green aviation.
The battery race: who will control the future of electric vehicles?
By Axel Miller | 08 Apr 2026
The global battery race is reshaping the electric vehicle industry, with China, the US, and Europe competing for control over supply chains and technology.
AI vs governments: Who controls the future of intelligence?
By Cygnus | 07 Apr 2026
Governments and AI companies like OpenAI and Anthropic are shaping the future of intelligence amid rising policy conflicts and global competition.
Strait of Hormuz: how one chokepoint controls the global economy
By Axel Miller | 06 Apr 2026
The Strait of Hormuz is a critical global chokepoint. Learn how disruptions impact oil prices, shipping, and the global economy.
The $2 trillion AI infrastructure race: Who will control global compute?
By Cygnus | 06 Apr 2026
AI spending is set to exceed $2 trillion in 2026, driving a global race in data centers, chips, and energy infrastructure.
